Medicare Enrolled
Dr. Igor Medic, M.D.
Hematology & Oncology · La Mesa, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Medic from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Medic?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Medic
Dr. Igor Medic is a hematology & oncology specialist in La Mesa, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Medic performed 132,442 Medicare services across 1,250 unique beneficiaries.
Between the years covered by Open Payments, Dr. Medic received a total of $10,101 from 76 pharmaceutical and/or device companies across 412 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Medic is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 5% volume in CA
$10,101 industry payments
Medicare Practice Summary
Medicare Utilization ↗132,442
Medicare services
Top 5% in CA for hematology & oncology
1,250
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9,460 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
58,500 | $1 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
40,100 | $2 | $10 |
| Pembrolizumab injection (Keytruda) | 20,000 | $43 | $90 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,855 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,560 | $1 | $17 |
| Injection, leucovorin calcium, per 50 mg | 1,604 | $3 | $7 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,032 | $2 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
929 | $101 | $200 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
626 | $14 | $40 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
452 | $118 | $295 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
396 | $93 | $559 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
350 | $12 | $45 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
261 | $7 | $28 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
198 | $56 | $140 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $67 | $134 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
159 | $30 | $73 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
122 | $59 | $140 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
121 | $29 | $84 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
107 | $1 | $4 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
106 | $25 | $64 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
105 | $2 | $4 |
| Blood draw from central venous catheter A procedure to collect a blood sample directly from a central venous tube or catheter. |
96 | $26 | $60 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
78 | $18 | $44 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
75 | $22 | $52 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
75 | $96 | $249 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
69 | $50 | $127 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $125 | $355 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
50 | $142 | $360 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
50 | $1 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
39 | $25 | $70 |
| New patient office visit, complex (60-74 min) | 39 | $184 | $385 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
31 | $16 | $45 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $140 | $270 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
45.1% high complexity
53.8% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,101
Total received (2018-2024)
Avg $1,443/year across 7 years
Top 32% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
412
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,301 (92.1%)
Other
Charitable contributions, space rental, and other categories
$607 (6.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$193 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,342
2023
$3,466
2022
$1,705
2021
$264
2020
$107
2019
$589
2018
$628
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$276
Novartis Pharmaceuticals Corporation
$263
Merck Sharp & Dohme LLC
$260
E.R. Squibb & Sons, L.L.C.
$237
Celgene Corporation
$214
Eisai Inc.
$151
AstraZeneca Pharmaceuticals LP
$146
Alexion Pharmaceuticals, Inc.
$136
Daiichi Sankyo Inc.
$134
ABBVIE INC.
$123
BeiGene USA, Inc.
$80
Janssen Biotech, Inc.
$79
Gilead Sciences, Inc.
$79
Astellas Pharma US Inc
$78
Incyte Corporation
$77
Genentech USA, Inc.
$75
ARRAY BIOPHARMA INC
$68
Deciphera Pharmaceuticals Inc.
$57
SpringWorks Therapeutics, Inc.
$54
Blueprint Medicines Corporation
$51
Bayer Healthcare Pharmaceuticals Inc.
$51
Exelixis Inc.
$50
PUMA BIOTECHNOLOGY, INC.
$50
SOBI, INC
$34
ADC Therapeutics America, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$27
TerSera Therapeutics LLC
$27
Ipsen Biopharmaceuticals, Inc
$27
GENZYME CORPORATION
$26
Tempus AI, Inc
$26
RECORDATI_RARE_DISEASES_INC.
$25
GlaxoSmithKline, LLC.
$24
TAIHO ONCOLOGY, INC.
$24
Mirati Therapeutics, Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$24
Pharmacosmos Therapeutics Inc.
$24
Novo Nordisk Inc
$23
Karyopharm Therapeutics Inc.
$23
Stemline Therapeutics Inc.
$22
Fennec Pharmaceuticals, Inc.
$20
Adaptive Biotechnologies Corporation
$20
Agios Pharmaceuticals, Inc.
$19
Immunocore Limited
$18
Aveo Pharmaceuticals, Inc.
$18
Lilly USA, LLC
$17
Sumitomo Pharma America, Inc.
$16
EMD Serono, Inc.
$16
Top 3 companies account for 23.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$965
E.R. Squibb & Sons, L.L.C.
$538
Celgene Corporation
$519
PFIZER INC.
$475
AstraZeneca Pharmaceuticals LP
$459
Merck Sharp & Dohme LLC
$388
NOVARTIS PHARMACEUTICALS CORPORATION
$299
GENZYME CORPORATION
$294
Astellas Pharma US Inc
$288
Exelixis Inc.
$279
Seagen Inc.
$268
Janssen Biotech, Inc.
$267
Eisai Inc.
$261
ABBVIE INC.
$217
Gilead Sciences, Inc.
$200
Incyte Corporation
$191
Amgen Inc.
$186
Alexion Pharmaceuticals, Inc.
$183
Daiichi Sankyo Inc.
$180
Bayer HealthCare Pharmaceuticals Inc.
$173
Blueprint Medicines Corporation
$173
Genentech USA, Inc.
$162
GlaxoSmithKline, LLC.
$161
Pharmacyclics LLC, An AbbVie Company
$159
ARRAY BIOPHARMA INC
$152
Clovis Oncology, Inc.
$145
BeiGene USA, Inc.
$138
Pharmacyclics LLC, an AbbVie Company
$135
Takeda Pharmaceuticals U.S.A., Inc.
$132
Regeneron Healthcare Solutions, Inc.
$122
Boston Scientific Corporation
$116
Karyopharm Therapeutics Inc.
$104
Bayer Healthcare Pharmaceuticals Inc.
$104
TerSera Therapeutics LLC
$102
Lilly USA, LLC
$99
Deciphera Pharmaceuticals Inc.
$89
Merck Sharp & Dohme Corporation
$88
Ipsen Biopharmaceuticals, Inc
$75
Adaptive Biotechnologies Corporation
$69
Coherus Biosciences Inc.
$69
ADC Therapeutics America, Inc.
$60
Stemline Therapeutics Inc.
$56
Rigel Pharmaceuticals, Inc.
$55
SpringWorks Therapeutics, Inc.
$54
Verastem, Inc.
$54
PUMA BIOTECHNOLOGY, INC.
$50
TAIHO ONCOLOGY, INC.
$48
Mirati Therapeutics, Inc.
$46
Sumitomo Pharma America, Inc.
$45
Novo Nordisk Inc
$42
Kyowa Kirin, Inc.
$41
SOBI, INC
$34
EMD Serono, Inc.
$32
Taiho Oncology, Inc.
$29
Tempus AI, Inc
$26
Octapharma USA, Inc.
$25
RECORDATI_RARE_DISEASES_INC.
$25
EUSA Pharma (US) LLC
$24
Pharmacosmos Therapeutics Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
MorphoSys, US Inc.
$22
EISAI INC.
$22
AbbVie Inc.
$20
Fennec Pharmaceuticals, Inc.
$20
Agios Pharmaceuticals, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
Apellis Pharmaceuticals, Inc.
$19
Tolmar, Inc.
$19
MENARINI SILICON BIOSYSTEMS, INC.
$18
Immunocore Limited
$18
Janssen Pharmaceuticals, Inc
$18
Aveo Pharmaceuticals, Inc.
$18
Foundation Medicine, Inc.
$17
Puma Biotechnology, Inc.
$17
Heron Therapeutics, Inc.
$14
Emmaus Medical, Inc.
$9
Top 3 companies account for 20.0% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALUNBRIG · AYVAKIT · Abraxane · Aliqopa · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · Cabometyx · Cellsearch · Columvi · Copiktra · DARZALEX · DOPTELET · ELIGARD · ELREXFIO · EMEND · EPKINLY · Empaveli · Endari · Enhertu · FARESTON · FOTIVDA · FOUNDATIONONE CDX · Fabhalta · GAZYVA · GENERAL BILIARY DEVICES · GILOTRIF · Gazyva · Hemlibra · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NINLARO · Nerlynx · Novoeight · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Pedmark · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SUSTOL · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Venclexta · Vitrakvi · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YERVOY · ZEJULA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
130
Per 100K population
4.0
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Medic is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Medic experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Medic performed 58,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Medic receive payments from pharmaceutical companies?
Yes. Dr. Medic received a total of $10,101 from 76 companies across 412 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Medic's costs compare to other hematology & oncology specialists in La Mesa?
Dr. Medic's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Medic) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in La Mesa
Browse hematology & oncology specialists in La Mesa ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology